Radioiodine (131I) Therapy of Graves' Disease: Use of the New High Resolutional Ultrasonic Scanner for the Determination of the Accurate Weight of the Thyroid Gland.
Open Access
- 1 January 1989
- journal article
- research article
- Published by Japan Endocrine Society in Endocrinologia Japonica
- Vol. 36 (3), 359-365
- https://doi.org/10.1507/endocrj1954.36.359
Abstract
In this series, eighteen patients with Graves' disease were treated with 8000 rads (80Gy) of radioiodine (131I), using the new high resolutional ultrasonic scanner for the determination of the accurate weight of the thyroid gland. The mean dose of radioiodine administered orally was 4.6± 3.0mCi (170.2±110.0 MBq) and 133.7± 44.6 μCi/g (4.95 ± 1.65 MBq). At one year after treatment, twelve of eighteen patients (66.7%) became euthyroid, five (27.8%) remained hyperthyroid and one (5.6%) became hypothyroid. Analysis of various factors which may be related to the effect of radioiodine therapy revealed that the weight of the thyroid gland in the hyperthyroid and euthyroid groups was significantly different (61.7±33.5g vs. 25.1±9.1 g, p<0.05). Furthermore, all patients with larger glands (more than sixty grams) remained hyperthyroid, while the incidence of euthyroidism was as high as 80% in patients with smaller glands (less than forty grams). Although the number of patients studied was small, these results indicate that a larger thyroid gland requires a larger radioiodine dose per gram of tissue than a smaller gland, suggesting that the therapeutic radiation dose should be graded according to the gland size even when the gland size is accurately estimated by ultrasound. Further study is required to determine the appropriate radiation dose graded according to the gland size.This publication has 11 references indexed in Scilit:
- Radioiodine Treatment of Graves' DiseaseAnnals of Internal Medicine, 1986
- Management of Hyperthyroidism in Children and AdolescentsJournal of Clinical Endocrinology & Metabolism, 1985
- Long-Term Follow-up Study of Compensated Low-Dose131I Therapy for Graves' DiseaseNew England Journal of Medicine, 1984
- Compensated Low-Dose ^131I Therapy of Graves' DiseaseAnnals of Internal Medicine, 1977
- Hypothyroidism After Low-Dose ^131I Treatment of HyperthyroidismAnnals of Internal Medicine, 1972
- Comparison of High and Low Dosage Levels of131I in the Treatment of ThyrotoxicosisNew England Journal of Medicine, 1967
- Rising Incidence of Hypothyroidism after Radioactive-Iodine Therapy in ThyrotoxicosisNew England Journal of Medicine, 1964
- Myxedema following radioactive iodine therapy of hyperthyroidismAmerican Journal Of Medicine, 1961
- Evaluation of Radioactive Iodine (I131) as a Treatment for HyperthyroidismNew England Journal of Medicine, 1959
- Clinical Experience in Diagnosis and Treatment of Thyroid Disorders with Radioactive Iodine (Eight-Day Half-Life)Radiology, 1948